<?xml version="1.0"?><rss version="2.0"><channel><title>biotechnology - Latest News</title><link>http://news.prlog.org/tag/biotechnology/</link><description>biotechnology - Latest News (Press Releases) - Read news before it's news</description><language>en-us</language><ttl>3600</ttl>
<item><title>The Inside Story Behind the Approval of the Gene Therapy Drug Glybera</title><link>http://www.prlog.org/12138234-the-inside-story-behind-the-approval-of-the-gene-therapy-drug-glybera.html</link><description>The scientists who led the team that developed Glybera, the first gene therapy drug approved for use in the Western world, provide a fascinating first-person account of their pioneering work in Human Gene Therapy.</description></item>
<item><title>Kindred Bio and Calico BioLabs Announce Identification of Antibody Candidates for Dogs</title><link>http://www.prlog.org/12131139-kindred-bio-and-calico-biolabs-announce-identification-of-antibody-candidates-for-dogs.html</link><description>Antibody therapy is expected to be a major advance in the treatment of dogs with severe immunologic conditions.</description></item>
<item><title>Fat Cells Prolong Survival of Human Stem Cells Grown In Vitro</title><link>http://www.prlog.org/12115083-fat-cells-prolong-survival-of-human-stem-cells-grown-in-vitro.html</link><description>One of the main obstacles that stands in the way of using human hematopoietic stem cells (hHSCs) to treat a variety of diseases is the difficulty growing them in culture—they quickly die or differentiate into other cell types.</description></item>
<item><title>IGDRASOL Announces Three Presentations on IG-001- paclitaxel polymeric micelle at AACR 2013</title><link>http://www.prlog.org/12109415-igdrasol-announces-three-presentations-on-ig-001-paclitaxel-polymeric-micelle-at-aacr-2013.html</link><description>IGDRASOL will present updates on Cynviloq™, its late clinical stage paclitaxel nanoparticle formulation.</description></item>
<item><title>Kindred Bio Announces the Filing of an INAD for Laminitis in Horses</title><link>http://www.prlog.org/12106685-kindred-bio-announces-the-filing-of-an-inad-for-laminitis-in-horses.html</link><description>KIND-005 is expected to be a major new therapy for the treatment of laminitis in...</description></item>
<item><title>Olivier Pasquier joins CYTOO as Chief Commercial Officer</title><link>http://www.prlog.org/12100626-olivier-pasquier-joins-cytoo-as-chief-commercial-officer.html</link><description>Grenoble, France, 18th March 2013, CYTOO, a life science systems &amp;amp; tools company providing disruptive solutions for cell-based assays and High Content Screening (HCS), is delighted to announce that Olivier Pasquier has joined the team as Chief...</description></item>
<item><title>Free Biotechnology Showcase at Harrisburg U for High School and Middle School Students</title><link>http://www.prlog.org/12098886-free-biotechnology-showcase-at-harrisburg-for-high-school-and-middle-school-students.html</link><description>The Capital Area Biotechnology Partnership’s free Biotechnology Showcase is set for April 17th at Harrisburg University of Science and Technology in PA.</description></item>
<item><title>Introducing new online programs in Bioscience/Biotechnology</title><link>http://www.prlog.org/12095139-introducing-new-online-programs-in-biosciencebiotechnology.html</link><description>The Online School will teach the learners Biotechnology, Bioscience, Biology, Biochemistry and integrate Social Sciences, Math, and hands-on practical laboratory experiments. Upon completion learners will be equipped for the scientific workforce.</description></item>
<item><title>Sorrento Therapeutics Signs Exclusive Option to Acquire IGDRASOL</title><link>http://www.prlog.org/12094030-sorrento-therapeutics-signs-exclusive-option-to-acquire-igdrasol.html</link><description>Sorrento Therapeutics, Inc. (&quot;STI&quot;; SRNE: OB) today announced that it has signed an exclusive option to acquire IGDRASOL, a private company focused on the development of oncologic agents for the treatment of cancers.</description></item>
<item><title>PharmaLeaders: Innovative Mid-Cap Biotechnology Benchmark Report</title><link>http://www.prlog.org/12087268-pharmaleaders-innovative-mid-cap-biotechnology-benchmark-report.html</link><description>Regeneron Named GlobalData’s Innovative Mid-Cap Biotech Benchmark Leader due to Eylea Territory Expansions</description></item>
<item><title>PolyScience Heated Circulating Baths Boast Temperature Stabilities as Precise as ±0.005°C</title><link>http://www.prlog.org/12082974-polyscience-heated-circulating-baths-boast-temperature-stabilities-as-precise-as-0005c.html</link><description>PolyScience heated circulating water baths, available in 23 different models, can achieve temperatures as high as 200°C with temperature stabilities as exacting as ±0.005°C.</description></item>
<item><title>Patent 27℠ Issues Call For Pilot Participation</title><link>http://www.prlog.org/12081898-patent-27-issues-call-for-pilot-participation.html</link><description>Dutch business intelligence publisher Patent 27℠ invites life sciences companies worldwide to participate in its pilot procedure. Patent 27 BV offers the first 250 participants a free bi-annual service contract.</description></item>
<item><title>IGDRASOL to present clinical data on NBN-paclitaxel at the AACR/JCA joint conference</title><link>http://www.prlog.org/12078760-igdrasol-to-present-clinical-data-on-nbn-paclitaxel-at-the-aacrjca-joint-conference.html</link><description>IGDRASOL today announced that the Company’s Chief Scientific Officer, Kouros Motamed, Ph.D., will present at the Breakthroughs in Basic &amp; Translational Cancer Research Conference, February 25th, 2013, Maui, HI.</description></item>
<item><title>Robert Lanza Appointed Editor-in-Chiefof BioResearch Open Access journal</title><link>http://www.prlog.org/12077423-robert-lanza-appointed-editor-in-chiefof-bioresearch-open-access-journal.html</link><description>Mary Ann Liebert, Inc., publishers is pleased to announce the appointment of Robert Lanza, MD as Editor-in-Chief of BioResearch Open Access effective immediately.</description></item>
<item><title>Introduction and Evolution of Animal Biotechnology</title><link>http://www.prlog.org/12077150-introduction-and-evolution-of-animal-biotechnology.html</link><description>Bharatbook.com glad to promote a new report on &quot;Animal Biotechnology - Technologies, Markets and Companies&quot; which gives in-depth analysis on the Animal Biotechnology.</description></item>
<item><title>The Delay In Approval Of Bt Brinjal Is Adversely Impacting R&amp;D In The Agriculture Sector: ABLE AG</title><link>http://www.prlog.org/12076113-the-delay-in-approval-of-bt-brinjal-is-adversely-impacting-rd-in-the-agriculture-sector-able-ag.html</link><description>ABLE-AG the apex industry body for the agri-biotech sector in the country, expressed its disappointment over the continued delay in the approval process for Bt brinjal, India’s first biotech food crop.</description></item>
<item><title>Inaugural 2013 Cures Within Reach Midwest BioScience Industry Campaign Honoring Michael Rosen</title><link>http://www.prlog.org/12073072-inaugural-2013-cures-within-reach-midwest-bioscience-industry-campaign-honoring-michael-rosen.html</link><description>On June 13th of 2013, diverse members of the Midwest BioScience Industry will be joining together in downtown Chicago around their common mission to improve the lives of patients suffering from catastrophic disease.</description></item>
<item><title>Kindred Bio Announces Filing of an Investigational New Animal Drug Application for KIND-002</title><link>http://www.prlog.org/12071533-kindred-bio-announces-filing-of-an-investigational-new-animal-drug-application-for-kind-002.html</link><description>KIND-002 is expected to be a major new therapy for severe cutaneous diseases in dogs.</description></item>
<item><title>'The contract vaccine manufacturing market will reach $0.62 billion in 2015' predicts Visiongain</title><link>http://www.prlog.org/12071433-the-contract-vaccine-manufacturing-market-will-reach-062-billion-in-2015-predicts-visiongain.html</link><description>A new report by visiongain predicts that the world market for vaccines will reach $48bn in 2015. From this market, vaccine contract manufacturing will reach $0.62bn in 2015.</description></item>
<item><title>CYTOO sponsors the Motility subgroup at the Biophysical Society meeting</title><link>http://www.prlog.org/12067825-cytoo-sponsors-the-motility-subgroup-at-the-biophysical-society-meeting.html</link><description>CYTOO will attend the BPS Annual Meeting in Philadelphia to present its innovative Cell Culture Platform, based on adhesive micropatterns. After the launch of the CYTOOplates Motility, the company has the pleasure to sponsor the Motility subgroup.</description></item>
<item><title>Record High Growth for Finnish Biotech Company HyTest Ltd.</title><link>http://www.prlog.org/12064082-record-high-growth-for-finnish-biotech-company-hytest-ltd.html</link><description>HyTest was able to maintain its high growth in 2012 despite the global economic downturn. Growth over the previous year is 25% and turnover at the end of the fiscal year ending in October was 12.7 million Euros (17 million USD).</description></item>
<item><title>Kindred Bio Elects Ervin Veszprémi, Former Head of Marketing, Novartis Animal Health, to Its Board</title><link>http://www.prlog.org/12064685-kindred-bio-elects-ervin-veszprmi-former-head-of-marketing-novartis-animal-health-to-its-board.html</link><description>Highly Regarded Veterinary Marketing Executive to Join Kindred Bio’s Board</description></item>
<item><title>IGDRASOL to present consolidated phase I data for IG-001 at AACR special conference</title><link>http://www.prlog.org/12062970-igdrasol-to-present-consolidated-phase-data-for-ig-001-at-aacr-special-conference.html</link><description>IGDRASOL today announced that the Company’s Chief Operating Officer, Larn Hwang, Ph.D., will present at the Tumor Invasion and Metastasis conference, January 21st , 2013, San Diego, CA.</description></item>
<item><title>BioAsia 2013, attracts regulators from across the globe</title><link>http://www.prlog.org/12061890-bioasia-2013-attracts-regulators-from-across-the-globe.html</link><description>‘BioAsia’ 2013 - officials from biopharma regulatory agencies across the globe. Prominent confirmations are USA, South Africa, Sri lanka, Philippines, Czech Republic, Malaysia, Jordan, republic of Lithuania, Ghana, London, Sweden and India.</description></item>
<item><title>Senior Level Pharma Experts Eagerly Anticipate 2013 Pharma Market Research Conference in New Jersey</title><link>http://www.prlog.org/12060473-senior-level-pharma-experts-eagerly-anticipate-2013-pharma-market-research-conference-in-new-jersey.html</link><description>Pharma industry experts buzzing about Pharma Market Research Conference on Feb 5-6. The event is selling out fast, so people are registering while they still have a chance.</description></item>
<item><title>Korilog unveils KLAST for sequence comparison in biological information systems</title><link>http://www.prlog.org/12056690-korilog-unveils-klast-for-sequence-comparison-in-biological-information-systems.html</link><description>Korilog, an IT specialist that designs solutions facilitating the use of heterogeneous biological information systems, has developed KLAST, a sequence-comparison technology for DNA, RNA and proteins.</description></item>
<item><title>Immune Response BioPharma, Inc. Posts 2nd Half 2012 &amp; Full Year Results</title><link>http://www.prlog.org/12054924-immune-response-biopharma-inc-posts-2nd-half-2012-full-year-results.html</link><description>Immune Response BioPharma, Inc. Posts 2nd Half 2012 &amp; Full Year Results</description></item>
<item><title>BioAsia forges prominent partnerships for its 10th edition – Spain joins in as the Country Partner</title><link>http://www.prlog.org/12054285-bioasia-forges-prominent-partnerships-for-its-10th-edition-spain-joins-in-as-the-country-partner.html</link><description>BioAsia,Asias biggest technology &amp; bio-business platform for Biotechnology &amp; Life sciences announced that Spain will be the Country Partner and GVK Biosciences will be the principal industry sponsor for the 10th edition of BioAsia – BioAsia 2013</description></item>
<item><title>Goose Launches Online &amp; Offline 2D Bar coding Solution with advanced Drug Packaging Authentication</title><link>http://www.prlog.org/12054334-goose-launches-online-offline-2d-bar-coding-solution-with-advanced-drug-packaging-authentication.html</link><description>‘Goose Tracker’ is designed to suit pharmaceutical industry’s urgent need to meet GS1 track and trace requirements, and ensure legislative compliance cost effectively</description></item>
<item><title>Kindred Bio Announces Filing of an Investigational New Animal Drug Application</title><link>http://www.prlog.org/12051215-kindred-bio-announces-filing-of-an-investigational-new-animal-drug-application.html</link><description>KIND-001, a potent and specific inhibitor of inflammatory cytokines, is expected to be a major new therapy for diseases in dogs.</description></item>
<item><title>IGDRASOL to present company platform at Biotech Showcase™ 2013</title><link>http://www.prlog.org/12049153-igdrasol-to-present-company-platform-at-biotech-showcase-2013.html</link><description>IGDRASOL today announced that Dr. Vuong Trieu, CEO of IGDRASOL, will discuss an overview of the company and the clinical development program for IG-001: a chemical polymer-bound nanoparticle paclitaxel entering phase III clinical testing.</description></item>
<item><title>Wescadia Group’s BioDeal 360™: Analysis of Deal Activity in the Australian Life Science Sector</title><link>http://www.prlog.org/12044978-wescadia-groups-biodeal-360-analysis-of-deal-activity-in-the-australian-life-science-sector.html</link><description>Wescadia Group, a healthcare consultancy firm, announces the release of its report “BioDeal 360™&quot;. The report provides strategic analysis, commentary, insight, and opinion on selected deals in the Australian life science industry in 2012.</description></item>
<item><title>IGDRASOL To Present Personalized Paclitaxel Therapy at Molecular Medicine Conference 2012</title><link>http://www.prlog.org/12044119-igdrasol-to-present-personalized-paclitaxel-therapy-at-molecular-medicine-conference-2012.html</link><description>Personalization of paclitaxel therapy by combination of next generation nanoparticle paclitaxel and point-of-care therapeutic drug monitoring and biomarker testing.</description></item>
<item><title>1,000 Pounds of Food Donated by Hepatitis B Foundation and PA Biotechnology Center</title><link>http://www.prlog.org/12042797-1000-pounds-of-food-donated-by-hepatitis-foundation-and-pa-biotechnology-center.html</link><description>The 6th Annual Holiday Food Drive sponsored by the Hepatitis B Foundation and Pennsylvania Biotechnology Center collects record amounts of food and cash donations for local food pantry.</description></item>
<item><title>Europe Gets Ready for New Year With Anticipation of 2013 Pharma CI Europe Conference in Zurich</title><link>http://www.prlog.org/12041799-europe-gets-ready-for-new-year-with-anticipation-of-2013-pharma-ci-europe-conference-in-zurich.html</link><description>Close Out 2012 Right By Making Sure You Sign Up for the 2013 Pharma CI Europe Conference at Zurich Marriott Hotel in on February 19-20, 2013.</description></item>
<item><title>Get Ready for the New Year by Signing Up for the 2013 Pharma Market Research Conference</title><link>http://www.prlog.org/12041764-get-ready-for-the-new-year-by-signing-up-for-the-2013-pharma-market-research-conference.html</link><description>Before Saying Goodbye to 2012, Make Sure You Say Hello to the 2013 Pharma Market Research Conference at Hilton Woodcliff Lake Hotel in New Jersey on February 5-6, 2013.</description></item>
<item><title>CYTOO's Motility Product Launch- Exclusive offer at ASCB 2012, December 15-19</title><link>http://www.prlog.org/12039850-cytoos-motility-product-launch-exclusive-offer-at-ascb-2012-december-15-19.html</link><description>CYTOO will offer a significant discount on all CYTOO Motility products at the ASCB 2012 Annual meeting in San Francisco: attendees are invited to visit ASCB Booth #329 for this exclusive offer!</description></item>
<item><title>CYTOO's Motility Plates to study cell migration to be launched at ASCB, december 15-19 2012</title><link>http://www.prlog.org/12035208-cytoos-motility-plates-to-study-cell-migration-to-be-launched-at-ascb-december-15-19-2012.html</link><description>CYTOO will launch the CYTOOplates Motility to study cell migration for screening applications in both oncology and drug discovery at the ASCB 2012 Annual meeting in San Francisco, USA.</description></item>
<item><title>Mettler Toledo's CO2 Sensor Improves Productivity</title><link>http://www.prlog.org/11725471-mettler-toledos-co2-sensor-improves-productivity.html</link><description>A new CO2 sensor combines precise and reliable determination of dissolved CO2, with the performance benefits of Intelligent Sensor Management.</description></item>
<item><title>DNA LABS INDIA Training notifications</title><link>http://www.prlog.org/12034571-dna-labs-india-training-notifications.html</link><description>DLI ranked by the Phoenix Business Journal as the No1 Bioinformatics training &amp; Biotechnology school in Hyderabad, India. This is now going to start a new batches in December 2012 .</description></item>
<item><title>New Venue for 2013 Pharma Market Research Conference is Hilton Woodcliff Lake Hotel in New Jersey</title><link>http://www.prlog.org/12032282-new-venue-for-2013-pharma-market-research-conference-is-hilton-woodcliff-lake-hotel-in-new-jersey.html</link><description>The new location for the 2013 Pharma Market Research Conference is the Hilton Woodcliff Lake Hotel in Woodcliff Lake, New Jersey. Excitement is building for this event that's critical to the pharmaceutical, biotechnology, and medical device industry.</description></item>
<item><title>BioAsia 2013- Global platform on Biotechnology Invites Nominations across Asia for Awards in Biotech</title><link>http://www.prlog.org/12026942-bioasia-2013-global-platform-on-biotechnology-invites-nominations-across-asia-for-awards-in-biotech.html</link><description>BioAsia, has opened the nomination process to all scientists &amp; students pursuing research in the areas of biotechnology / life sciences or have made a significant contribution to the field of life sciences industry.</description></item>
<item><title>Kindred Bio Elects Dr. Ernest Mario, Former CEO of Glaxo, to Its Board of Directors</title><link>http://www.prlog.org/12016324-kindred-bio-elects-dr-ernest-mario-former-ceo-of-glaxo-to-its-board-of-directors.html</link><description>Distinguished Pharmaceutical Executive to Join Kindred Bio’s Board</description></item>
<item><title>Kalos Therapeutics, Inc. accepted into CONNECT’s Get Coached to Get Capital program</title><link>http://www.prlog.org/12009602-kalos-therapeutics-inc-accepted-into-connects-get-coached-to-get-capital-program.html</link><description>Kalos has recently been accepted into the new Get Coached to Get Capital program offered by CONNECT, a San Diego-based innovation accelerator. The program seeks innovation and offers coaching to give a high-profile presentation to investors.</description></item>
<item><title>Manu Marketing Presents Fusion 2013 Montreal</title><link>http://www.prlog.org/12006155-manu-marketing-presents-fusion-2013-montreal.html</link><description>An event for buyers and suppliers in the pharmaceutical, biotechnology, and natural health products industries</description></item>
<item><title>engageIndia announces partnership with FABA</title><link>http://www.prlog.org/12003936-engageindia-announces-partnership-with-faba.html</link><description>engageIndia has partnered with the ultimate global forum on Lifesciences, BioAsia, India to connect, discuss, explore and drive a bio-future poised to be shaped by the next industry trends: Biologics and Biosimilars.</description></item>
<item><title>Healthcare, Pharma experts delve into 2013’s most pressing issues at critical pharmaceutical event</title><link>http://www.prlog.org/12001755-healthcare-pharma-experts-delve-into-2013s-most-pressing-issues-at-critical-pharmaceutical-event.html</link><description>The just-released program agenda for the 2013 Pharma CI Europe Conference reveals 35+ expert speakers delving into the most critical issues for the pharmaceutical, biotechnology competitive intelligence community.</description></item>
<item><title>Scientists call on French researchers to release GMO test data</title><link>http://www.prlog.org/11999640-scientists-call-on-french-researchers-to-release-gmo-test-data.html</link><description>More than 700 scientists and academicians have signed petitions calling on French researcher Gilles-Eric Seralini to release research data behind his recently publicized health claims associated with biotech crops.</description></item>
<item><title>Kindred Bio &amp; Single Cell Partner to Develop Antibodies for Treatment of Diseases in Pets</title><link>http://www.prlog.org/11995153-kindred-bio-single-cell-partner-to-develop-antibodies-for-treatment-of-diseases-in-pets.html</link><description>Breakthrough technology to save lives and alleviate suffering in dogs, cats, and horses</description></item>
<item><title>Eighth Annual BioSciences Forum Speakers Announced</title><link>http://www.prlog.org/11993047-eighth-annual-biosciences-forum-speakers-announced.html</link><description>The NC State Poole College of Management presents its Eighth Annual BioSciences Forum on Friday, October 26, 2012. There is no cost to attend but registration is required.</description></item></channel></rss>